India patent case threatens cheap drug supply: MSF
Supply of cheap, copycat drugs for the developing world could be badly threatened if Swiss firm Novartis wins a challenge to India's patent law, medical charity MSF said on Monday.
Medications
Sep 05, 2011 |
5 / 5 (4) |
1
India rejects Bayer plea against cheap cancer drug (Update)
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting ...
Medications
Mar 05, 2013 |
5 / 5 (4) |
3
Switching antiepileptic drugs could increase risk of seizures
The substitution of brand-name antiepileptic drugs with cheaper generic equivalents has been an ongoing point of contention among doctors, federal officials and people with epilepsy.
Medications
Feb 17, 2012 |
5 / 5 (2) |
0
|
Soviet-era pill from Bulgaria helps smokers quit
(AP) -- A pill developed in Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big study of it shows.
Health
Sep 28, 2011 |
4.5 / 5 (2) |
0
FDA approves first generic versions of Zyprexa
(AP) -- Federal health officials on Monday approved the first generic versions of the blockbuster drug Zyprexa, an expensive treatment for schizophrenia and bipolar mood disorder.
Medications
Oct 24, 2011 |
3 / 5 (2) |
0
US approves India's Ranbaxy to make generic Lipitor
Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.
Medications
Dec 01, 2011 |
5 / 5 (1) |
0
Supreme Court ruling supports generic drug makers
The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.
Medications
Apr 18, 2012 |
5 / 5 (1) |
0
US says Teva antidepressant is ineffective
(AP)—Teva Pharmaceuticals has stopped shipping its generic version of a popular antidepressant off the market after a U.S. government analysis showed the pill does not work properly.
Medications
Oct 03, 2012 |
5 / 5 (1) |
0
Regenstrief study finds that generic drugs often have incorrect safety labeling
Despite U.S. Food and Drug Administration regulations requiring generic medications to carry identical warnings to those on corresponding brand-name products, a study by Regenstrief Institute researchers has found that more ...
Medications
Dec 13, 2012 |
5 / 5 (1) |
0
